Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2841782 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Integrin-Linked Kinase (ILK) (AA 225-253), (Ser246) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 225-253, Ser246
- Antibody clone number
- RB13868
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro.
CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt.
Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.
Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
Cordes N, van Beuningen D
British journal of cancer 2003 May 6;88(9):1470-9
British journal of cancer 2003 May 6;88(9):1470-9
CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt.
Fukuda T, Guo L, Shi X, Wu C
The Journal of cell biology 2003 Mar 31;160(7):1001-8
The Journal of cell biology 2003 Mar 31;160(7):1001-8
Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.
Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S
The Journal of biological chemistry 2003 Jun 20;278(25):22374-8
The Journal of biological chemistry 2003 Jun 20;278(25):22374-8
Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
Marotta A, Parhar K, Owen D, Dedhar S, Salh B
British journal of cancer 2003 Jun 2;88(11):1755-62
British journal of cancer 2003 Jun 2;88(11):1755-62
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC